In a strategic move to bolster its expertise in regulatory affairs, King & Spalding has announced the appointment of Lauren Roth as a partner within its Food and Drug Administration (FDA) and life sciences team. Roth joins the government’s matters and regulation practice group in the firm’s Washington office. This appointment was made public by the firm on Wednesday.
Roth brings a wealth of experience from her previous tenure at the FDA, where she held multiple leadership roles. Notably, she served as the associate commissioner for policy within the FDA’s Office of the Commissioner. In this role, Roth was instrumental in shaping and implementing complex and innovative policies across the FDA’s spectrum of regulatory responsibilities. This experience positions her uniquely to contribute to King & Spalding’s regulatory practice, particularly in navigating the intricacies of FDA policies.
The addition of Roth underscores King & Spalding’s commitment to enhancing its regulatory and policy expertise in response to the dynamic legal challenges facing clients within the life sciences sector. For more details on Roth’s appointment and her role at King & Spalding, read the full article on Bloomberg Law.